Abstract
The future of pharmaceutical drug development is being increasingly shaped by precision medicine, which tailors treatment to individual genetic profiles. This paradigm shift offers a more targeted and effective approach to treating diseases, particularly cancer, cardiovascular diseases, and rare genetic disorders. By leveraging genetic, environmental, and lifestyle data, precision medicine promises to enhance drug efficacy and minimize adverse effects. This article explores the evolution of pharmaceutical drug development, the integration of precision medicine into drug discovery and design, and the challenges and opportunities this approach presents.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Dr. John Smith (Author)